The goal of this trial is to determine if the addition of the Heart Logic diagnostic alerts to standard of care therapies will lessen hospitalizations and improve quality of life in patients with heart failure.
Investigator-sponsored post-market, randomized, multicenter trial evaluating the HeartLogic diagnostic in optimizing GDMT in patients with chronically low EF
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
135
Heart Logic threshold set to 10 (from 16)
Heartlogic Threshold to remain at 16, which is the normal limit.
Ascension St. Vincent Medical Group
Indianapolis, Indiana, United States
Saint Thomas Heart at Saint Thomas Midtown
Nashville, Tennessee, United States
Hospitalizations
Number of Hospitalizations
Time frame: 365 Days
Number of ICD Shocks
Number of ICD shocks due to VT, VF and changes to AFib burden
Time frame: 365 Days
nt-ProBNP
Changes to nt-proBNP
Time frame: 365 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.